Enveric Biosciences, Inc.

NASDAQ (USD): Enveric Biosciences, Inc. (ENVB)

Last Price

0.412

Today's Change

-0.008 (1.90%)

Day's Change

0.41 - 0.431

Trading Volume

46,732

Profile
ENVB

Exchange:  NASDAQ Capital Market NASDAQ Capital Market

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Dr. Joseph Edward Tucker Ph.D. Dr. Joseph Edward Tucker Ph.D.

Full Time Employees:  7 7

IPO Date:  2015-05-04 2015-05-04

CIK:  0000890821 0000890821

ISIN:  US29405E2081 US29405E2081

CUSIP:  29405E208 29405E208

Beta:  0.50 0.50

Last Dividend:  0.00 0.00

Dcf Diff:  -0.63 -0.63

Dcf:  1.06 1.06

Description

Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.

Address

4851 Tamiami Trail North,
Naples, FL 34103, US

239 302 1707

http://www.enveric.com

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment